Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
Interest Income Over TimeStrong
Percentile Rank83
3Y CAGR+57.3%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+57.3%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
3.9x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$18.47M-6.2%
2024$19.70M+14.6%
2023$17.19M+262.1%
2022$4.75M+118550.0%
2021$4000.00-
2020$0.00-
2019$0.00-